Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions

被引:20
|
作者
Hesketh, Shirley A. [2 ]
Brennan, Adrian K. [1 ]
Jessop, David S. [2 ]
Finn, David P. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Ctr Pain Res, Dept Pharmacol & Therapeut, Natl Ctr Biomed Engn Sci Neurosci Cluster, Galway, Ireland
[2] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England
基金
爱尔兰科学基金会;
关键词
antidepressant; rat; cannabinoids; opioid receptor; paraventricular nucleus; hippocampus; S-35]GTP gamma S autoradiography;
D O I
10.1007/s00213-007-1033-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale There is growing interest in investigating the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs), beyond their association with the serotonergic system, due to their wide therapeutic potential for disorders including depression, pain and addiction. Objective The aim of this study was to investigate whether chronic treatment with the SSRI, citalopram, alters the functional coupling of G(i/o)-associated cannabinoid type 1 (CB1) and mu-opioid receptors in selected areas of rat brain implicated in psychiatric disorders and pain. Methods Using an autoradiographic approach, the effects of the cannabinoid receptor agonist, HU210 (in the presence or absence of the CB1 receptor antagonist AM251), or the mu-opioid receptor agonist, [D-Ala(2),N-Me-Phe4,Gly(5)-ol]-enkephalin (DAMGO; in the presence or absence of the mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2), on [S-35]GTP gamma S binding in discrete brain regions of citalopram-treated (10 mg kg(-1) day(-1) for 14 days by subcutaneous minipump) and control rats were investigated. Results The HU210-induced increase in [S-35]GTP gamma S binding observed in the hypothalamic paraventricular nucleus of control rats was abolished after chronic treatment with citalopram. Reduced response to HU210 in rats receiving chronic treatment with citalopram was also observed in the hippocampus and medial geniculate nucleus. Citalopram had no significant effect on DAMGO-induced [S-35]GTP gamma S binding in the brain regions investigated, with the exception of the medial geniculate nucleus where a modest impairment was observed. Conclusions These data provide evidence for reduced cannabinoid receptor-mediated G-protein coupling in the hypothalamus, hippocampus and medial geniculate nucleus of rats chronically treated with citalopram, effects which may, in part, underlie the mechanism of action of SSRIs.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [11] INVIVO RECEPTOR-MEDIATED PHOSPHORYLATION OF A G-PROTEIN IN DICTYOSTELIUM
    GUNDERSEN, RE
    DEVREOTES, PN
    SCIENCE, 1990, 248 (4955) : 591 - 593
  • [12] Blockade of μ-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice
    Mizoguchi, H
    Hung, K
    Leitermann, R
    Narita, M
    Nagase, H
    Suzuki, T
    Tseng, LF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 461 (01) : 35 - 39
  • [13] Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries
    Lozahic, Caroline
    Maddock, Helen
    Wheatley, Mark
    Sandhu, Hardip
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (08) : 5831 - 5845
  • [14] G-protein coupling of δ-opioid receptors in brains of μ-opioid receptor knockout mice
    Oakley, SM
    Toth, G
    Borsodi, A
    Kieffer, BL
    Kitchen, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 466 (1-2) : 91 - 98
  • [15] Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration
    Maher, CE
    Martin, TJ
    Childers, SR
    LIFE SCIENCES, 2005, 77 (10) : 1140 - 1154
  • [16] Loss of μ-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of μ-opioid receptor gene
    Mizoguchi, H
    Wu, HE
    Narita, M
    Loh, HH
    Nagase, H
    Tseng, LF
    NEUROSCIENCE LETTERS, 2002, 335 (02) : 91 - 94
  • [17] Antagonistic property of buprenorphine for putative ε-opioid receptor-mediated G-protein activation by β-endorphin in pons/medulla of the μ-opioid receptor knockout mouse
    Mizoguchi, H
    Wu, HE
    Narita, M
    Hall, FS
    Sora, I
    Uhl, GR
    Nagase, H
    Tseng, LF
    NEUROSCIENCE, 2002, 115 (03) : 715 - 721
  • [18] THE EFFECTS OF AGING ON MUSCARINIC RECEPTOR/G-PROTEIN COUPLING IN THE RAT HIPPOCAMPUS AND STRIATUM
    ANSON, RM
    CUTLER, R
    JOSEPH, JA
    YAMAGAMI, K
    ROTH, GS
    BRAIN RESEARCH, 1992, 598 (1-2) : 302 - 306
  • [19] Opioid and cannabinoid receptor protein levels following chronic treatment
    Cichewicz, DL
    Welch, SP
    FASEB JOURNAL, 2001, 15 (04): : A228 - A228
  • [20] THE PERIPHERAL CANNABINOID RECEPTOR - ADENYLATE-CYCLASE INHIBITION AND G-PROTEIN COUPLING
    BAYEWITCH, M
    AVIDORREISS, T
    LEVY, R
    BARG, J
    MECHOULAM, R
    VOGEL, Z
    FEBS LETTERS, 1995, 375 (1-2) : 143 - 147